Immunovant, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
IMVT on Nasdaq
Location
320 West 37 Th Street, New York, NY

Insiders trading volume in the past year

Immunovant, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Roivant Sciences Ltd. Director, 10%+ Owner $1.93B +$337M +21.1% Jan 13, 2025
Peter Salzmann Chief Executive Officer, Director $23.3M -$4.12M -15% Jan 15, 2025
Frank Torti Director $23M Apr 2, 2024
Julia G. Butchko Chief Development Officer $14.3M -$725K -4.84% Aug 21, 2024
William L. Macias Chief Medical Officer $8.69M -$838K -8.79% Jan 15, 2025
Mark S. Levine Chief Legal Officer $8.12M -$1.17M -12.6% Nov 20, 2024
Eva Renee Barnett Chief Financial Officer $7.86M -$1.55M -16.5% Jan 15, 2025
George V. Migausky Director $4.38M Apr 2, 2024
Andrew J. Fromkin Director $3.61M Apr 2, 2024
Douglas J. Hughes Director $3.41M -$155K -4.34% Dec 2, 2024
Jay S. Stout Chief Technology Officer $3.3M -$420K -11.3% Jan 22, 2025
Melanie Gloria Chief Operating Officer $3.25M Nov 18, 2024
Christopher Van Tuyl Chief Legal Officer $3.14M Dec 16, 2024
Michael Geffner Chief Medical Officer $3.12M -$347K -10% Jan 22, 2025
Atul Pande Director $3.04M -$221K -6.77% Dec 2, 2024

Recent Insider Transactions by Companies or Individuals for Immunovant, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.